Tags

Type your tag names separated by a space and hit enter

Immunocompromised travellers.
Int Marit Health. 2017; 68(4):229-237.IM

Abstract

Given a better quality of life and extended life expectancy in patients with immune suppression, the number of immunocompromised travellers is constantly growing. The aim of the article is to discuss travel-related health problems in immunocompromised patients, their most common destinations and reasons to travel, as well as complications associated with travel to regions with harsh environmental conditions. The article focuses on selected groups of immunocompromised travellers (ICTs), i.e., cancer patients, transplant patients receiving immunosuppressant agents, splenectomised patients and HIV-infected individuals. The most common infections and complications, including traveller's diarrhoea, vector-borne diseases (yellow fever, malaria, leishmaniasis, dengue, chikungunya), respiratory infections (including tuberculosis), and dermatoses were taken into account. Preventive measures dedicated to ICTs (pre-travel consultation, vaccinations, malaria chemoprophylaxis, prevention during travelling) have been also characterised.

Authors+Show Affiliations

No affiliation info availableDepartment of Epidemiology and Tropical Medicine in Gdynia, Military Institute of Medicine, Poland. kktropmed@wp.pl.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

29297574

Citation

Wasilczuk, Katarzyna, and Krzysztof Korzeniewski. "Immunocompromised Travellers." International Maritime Health, vol. 68, no. 4, 2017, pp. 229-237.
Wasilczuk K, Korzeniewski K. Immunocompromised travellers. Int Marit Health. 2017;68(4):229-237.
Wasilczuk, K., & Korzeniewski, K. (2017). Immunocompromised travellers. International Maritime Health, 68(4), 229-237. https://doi.org/10.5603/IMH.2017.0041
Wasilczuk K, Korzeniewski K. Immunocompromised Travellers. Int Marit Health. 2017;68(4):229-237. PubMed PMID: 29297574.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immunocompromised travellers. AU - Wasilczuk,Katarzyna, AU - Korzeniewski,Krzysztof, PY - 2017/10/08/received PY - 2017/12/11/accepted PY - 2018/1/4/entrez PY - 2018/1/4/pubmed PY - 2018/8/21/medline KW - immunocompromised patients KW - travelling KW - tropics SP - 229 EP - 237 JF - International maritime health JO - Int Marit Health VL - 68 IS - 4 N2 - Given a better quality of life and extended life expectancy in patients with immune suppression, the number of immunocompromised travellers is constantly growing. The aim of the article is to discuss travel-related health problems in immunocompromised patients, their most common destinations and reasons to travel, as well as complications associated with travel to regions with harsh environmental conditions. The article focuses on selected groups of immunocompromised travellers (ICTs), i.e., cancer patients, transplant patients receiving immunosuppressant agents, splenectomised patients and HIV-infected individuals. The most common infections and complications, including traveller's diarrhoea, vector-borne diseases (yellow fever, malaria, leishmaniasis, dengue, chikungunya), respiratory infections (including tuberculosis), and dermatoses were taken into account. Preventive measures dedicated to ICTs (pre-travel consultation, vaccinations, malaria chemoprophylaxis, prevention during travelling) have been also characterised. SN - 2081-3252 UR - https://www.unboundmedicine.com/medline/citation/29297574/Immunocompromised_travellers_ L2 - https://journals.viamedica.pl/international_maritime_health/article/view/55573 DB - PRIME DP - Unbound Medicine ER -